AI biotech Isomorphic Labs is not slowing down, exec says
This story is from 2026-09-15. It is preserved in the archive; the latest stories are on the live feed.
“All of our AI models are locked down and locked down in-house,” Chris Butler, who runs drug discovery at the Google-backed drug company, said at Semafor’s Future of Health Forum.
Read the full story at Semafor Technology ↗
Timeline · 1 report
- 2026-09-15 17:26 · Semafor Technology
AI biotech Isomorphic Labs is not slowing down, exec says